West Pharmaceutical Services, Inc. (WST)
273.73
+3.92
(+1.45%)
USD |
NYSE |
Apr 17, 16:00
273.67
-0.06
(-0.02%)
Pre-Market: 20:00
West Pharmaceutical Services Research and Development Expense (Quarterly) : 21.80M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 306.00M |
| Intuitive Surgical, Inc. | 352.90M |
| Baxter International, Inc. | 116.00M |
| Align Technology, Inc. | 83.04M |
| Abbott Laboratories | 756.00M |